Kyverna Therapeutics Stock (NASDAQ: KYTX) stock price, news, charts, stock research, profile.
You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.
Other companies in Kyverna Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Anixa Biosciences (NASDAQ:ANIX), Cabaletta Bio (NASDAQ:CABA), Atossa Therapeutics (NASDAQ:ATOS) and Elicio Therapeutics (NASDAQ:ELTX).
Kyverna Therapeutics has a consensus price target of $23.20.
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $2.825 last updated February 20, 2025 at 4:29 PM EST.
There are no upcoming dividends for Kyverna Therapeutics.
Kyverna Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Kyverna Therapeutics.
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.